# A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus

> **NCT00882726** · PHASE1 · COMPLETED · sponsor: **Centocor, Inc.** · enrollment: 133 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** CNTO 3649 IV (Healthy participants)
- **DRUG:** CNTO 3649 SC (Healthy participants)
- **DRUG:** CNTO 3649 SC (Diabetic patients)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00882726
- **Lead sponsor:** Centocor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2013-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00882726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00882726, "A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00882726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*